Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × sepantronium × Clear all

NCT00818480 2015-09-04

An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155

Phase 2 Completed

DermatologicGenitourinaryLymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Melanoma, Prostatic Neoplasms

NCT00257478 2012-06-07

A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy

Phase 2 Completed

Prostatic Neoplasms